RBC Capital analyst Conor McNamara maintained a Maintain ranking on Hologic (HOLX – Analysis Report) on January 24 and set a worth goal of $76.00. The corporate’s shares closed yesterday at $74.41.
In keeping with TipRanks, McNamara is an analyst with a mean return of -10.0% and a 38.81% success price. McNamara covers the Healthcare sector, specializing in shares reminiscent of Illumina, QuidelOrtho, and SOPHiA GENETICS.
Hologic has an analyst consensus of Average Purchase, with a worth goal consensus of $80.10.
See Insiders’ Sizzling Shares on TipRanks >>
HOLX market cap is at the moment $17.4B and has a P/E ratio of 40.54.
Primarily based on the current company insider exercise of 53 insiders, company insider sentiment is unfavourable on the inventory. Because of this over the previous quarter there was a rise of insiders promoting their shares of HOLX in relation to earlier this yr.
TipRanks has tracked 36,000 firm insiders and located that just a few of them are higher than others in the case of timing their transactions. See which 3 shares are most certainly to make strikes following their insider actions.
Hologic (HOLX) Firm Description:
Hologic, Inc. engages within the growth, manufacture, and provide of diagnostics merchandise, medical imaging techniques, and surgical merchandise devoted to serve the healthcare wants of girls. It operates via the next enterprise segments: Breast Well being, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Well being. The Breast Well being section features a broad portfolio of breast imaging and associated merchandise and equipment, together with digital mammography techniques, computer-aided detection, for mammography and minimally invasive breast biopsy gadgets, breast biopsy web site markers, and breast biopsy steering techniques. The Diagnostics section includes Aptima household of Assays, goal seize/nucleic acid extraction techonolgy, transcription-mediated amplification know-how, hybridization safety assay and twin kinetic assat applied sciences, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics section provides SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Contact. The GYN Surgical section encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Elimination System. The Skeletal Well being section covers the invention and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis evaluation product, and Fluoroscan mini C-arm imaging merchandise. The corporate was based by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.
Learn Extra on HOLX:
